Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vanda Pharmaceuticals Inc (NASDAQ:VNDA)

15.90
Delayed Data
As of Aug 18
 -0.15 / -0.93%
Today’s Change
11.58
Today|||52-Week Range
18.00
-0.31%
Year-to-Date

Today’s Trading

Previous close16.05
Today’s open15.95
Day’s range15.85 - 16.20
Volume299,394
Average volume (3 months)461,431
Market cap$713.2M
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)+56.38%
Earnings growth (this year)-773.33%
Earnings growth (next 5 years)+19.10%
Revenue growth (last year)+32.83%
P/E ratioNM
Price/Sales4.75
Price/Book5.33

Competitors

 Today’s
change
Today’s
% change
RVNCRevance Therapeutics...-0.30-1.28%
ZIOPZIOPHARM Oncology In...-0.16-3.11%
AKBAAkebia Therapeutics ...-0.03-0.20%
HSKAHeska Corp-0.80-0.81%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$146.0M
Annual profit (last year)-$18.0M
Net profit margin-12.33%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mihael Hristos Polymeropoulos
Chief Financial Officer, Treasurer &
Senior VP
James Patrick Kelly
Corporate headquarters
Washington, District Of Columbia

Forecasts